ALX Oncology Exchanges 13,353,384 Common Shares for Pre-Funded Warrants
Bitget2026/10/15 20:56- ALX Oncology agreed October 14, 2026, to exchange 13,353,384 common shares for pre-funded warrants covering the same number of shares.
- Blackstone-affiliated funds account for 12,885,891 shares; RA Capital Healthcare Fund, 213,667; venBio Global Strategic Fund, 253,826.
- The unregistered issuance relies on a Section 3(a)(9) exemption, with settlement expected on or about October 15, 2026.
- Warrants carry a $0.001-per-share exercise price, exercisable from issuance until fully exercised through cash payment or cashless exercise.
- Exercise is subject to 4.99% or 9.99% ownership caps; holders may raise caps to 19.99%, effective 61 days following notice.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street fixed income trading enters an early "winter," European banks expected to face pressure next
The weak performance of Wall Street banks’ fixed income business in the third quarter is not a good sign for European banks, as they are also facing challenges from rising interest rates.
Federal Reserve Chairman Waller supports AI boosting the economy, improving sentiment in emerging markets
Federal Reserve Governor Waller is optimistic about AI boosting the economy, and emerging market indices saw their first rise this week; Indonesia’s stock and currency markets suffered as MSCI considered a downgrade, while Malaysia’s GDP grew by 5.3% thanks to stronger-than-expected AI-related exports.
RBC lowers the target price of Albemarle in the United States to $129.
Crypto prices
More
